Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults with Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials

  • Susanne Ostrowitzki
  • , Tobias Bittner
  • , Kaycee M. Sink
  • , Howard Mackey
  • , Christina Rabe
  • , Lawrence S. Honig
  • , Emanuele Cassetta
  • , Michael Woodward
  • , Mercè Boada
  • , Christopher H. Van Dyck
  • , Timo Grimmer
  • , Dennis J. Selkoe
  • , Andres Schneider
  • , Kathleen Blondeau
  • , Nan Hu
  • , Angelica Quartino
  • , David Clayton
  • , Michael Dolton
  • , Yifan Dang
  • , Beth Ostaszewski
    • Sandra M. Sanabria-Bohórquez, Michael Rabbia, Balazs Toth, Udo Eichenlaub, Jillian Smith, Lee A. Honigberg, Rachelle S. Doody

Research output: Contribution to journal › Article › peer-review

163 Scopus citations

Fingerprint

Dive into the research topics of 'Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults with Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science